animal models of focal cerebral ischemia are well accepted for investigating the pathogenesis and potential treatment strategies for human stroke. occlusion of the middle cerebral artery (Mca) with an endovascular filament is a widely used model to induce focal cerebral ischemia. However, this model is not amenable to thrombolytic therapies. as thrombolysis with recombinant tissue plasminogen activator (rtpa) is a standard of care within 4.5 h of human stroke onset, suitable animal models that mimic cellular and molecular mechanisms of thrombosis and thrombolysis of stroke are required. By occluding the Mca with a fibrin-rich allogeneic clot, we previously developed an embolic model of Mca occlusion in the rat, which recapitulates the key components of thrombotic development and of thrombolytic therapy of rtpa observed from human ischemic stroke. Here we describe in detail the surgical procedures of our model, including preparing emboli from rat donors. these procedures can be typically completed within ~30 min, and they are highly adaptable to other strains of rats, as well as mice, in both sexes. thus, this model provides a powerful tool for translational stroke research. The main limitation of our model is that it specifically blocks the origin of the MCA, which produces a large ischemic lesion that encompasses the entire MCA territory. However, with modification of the embolus length, a small cortical ischemic lesion in downstream MCA territory can be produced 31 .
IntroDuctIon
Stroke is a leading cause of death and disability, affecting 15 million people globally each year. Over 80% of stroke is caused by the obstruction of a cerebral artery by an endovascular embolus or thrombus formation. Unfortunately, treatment options for stroke are limited. Since approval by the US Food and Drug Administration in 1996, i.v. administration of rtPA, which dissolves the obstructive clot to restore blood flow 1 , remains the only treatment for patients within 4.5 h of stroke onset. However, only a small percentage of patients with ischemic stroke are eligible for rtPA treatment, owing to its narrow therapeutic window and the risk of brain hemorrhage [2] [3] [4] . To improve our understanding of the pathogenesis of stroke and to bring thrombolytic therapy and other potential therapeutic approaches to more stroke patients, suitable animal models that mimic the pathophysiology of ischemic stroke are required.
Human stroke most frequently affects the territory of the MCA 5 . Spontaneous thrombolytic lysis occurs in human stroke 6 . Occlusion of the MCA by various methods in rodents generates reproducible ischemic brain damage and has been widely used to study the underlying molecular mechanisms and potential treatment strategies for stroke. Occlusion of the MCA with an intraluminal filament is the most frequently used minimally invasive stroke model in rodents, which allows retraction of the filament from the MCA at variable durations to produce permanent or transient focal ischemia 7 . However, re-perfusion achieved by retraction of the filament cannot model the biological events of thrombolysis 8 . There are additional models for inducing stroke, all with merits and limitations ( Table 1) . Notably, large failures of neuroprotective clinical trials for acute stroke treatment highlight that neuroprotection alone without restoration of tissue perfusion and vascular integrity may not be adequate for treatment of acute stroke [9] [10] [11] [12] . Treatment of acute stroke needs to restore the normal function of the neurovascular unit by rapidly re-establishing cerebral blood flow in the ischemic cerebral microvascular bed, preserving vascular integrity and minimizing cell death 13 .
We developed a clinically relevant model of embolic ischemia in the rat that closely mimics the pathological features of thromboembolic stroke [14] [15] [16] . By precise delivery of a naturally formed allogeneic embolus to the origin of the MCA, we observe the dynamic development of thrombotic formation at the embolic occluded MCA site and the secondary thrombosis in the downstream cerebral microvessels of the MCA [14] [15] [16] . The ischemic cell damage is predictable and reproducible, which is well confined within the territory supplied by the MCA [14] [15] [16] . Longitudinal MRI analysis of this model reveals spontaneous recanalization of the occluded MCA ~24 h or later after stroke 17 . Moreover, i.v. administration of rtPA within 2 h of MCA occlusion (MCAO) promotes recanalization, substantially improves downstream microvascular perfusion and integrity and considerably reduces infarct size, consequently leading to improved neurological outcomes [18] [19] [20] . Thus, this model provides the key components of thromboembolic development and of thrombolytic therapy of rtPA observed in human ischemic stroke 21, 22 . This embolic model of focal cerebral ischemia has been widely used for the evaluation of thrombolytic therapies and potential adjuvant agents to thrombolysis [23] [24] [25] [26] [27] [28] [29] [30] . Here we provide a detailed protocol on how to generate this model starting from the preparation of an embolus. The surgical procedures to occlude the MCA are minimally invasive, and they can be typically completed within 30 min.
Advantages and limitations
The key advantages of our model are as follows:
A single embolus blocks the origin of the MCA. Thus, the ischemic cell damage is well confined within the territory supplied by the MCA, leading to predicable and reproducible focal cerebral ischemia. Secondary thrombosis is formed at the site at which the embolus resided and in downstream cerebral microvessels. Spontaneous recanalization of the occluded MCA occurs at 24 h or later. Impairment of sensorimotor function can be assayed. Intravenous administration of rtPA within 2 h of the onset of MCAO induces recanalization, increases downstream microvascular perfusion and reduces ischemic cell damage. Adjunct use of rtPA with neuroprotective agents extends the therapeutic window of thrombolysis and reduces hemorrhagic transformation. 2| Place the rat in supine position and retract both hind limbs posteriorly and laterally to expose the femoral triangle.
Hold the limbs in position with surgical tapes, and shave the inguinal region over the right femoral triangle with a clipper.
3|
Apply 10% povidone-iodine and 70% isopropyl alcohol pads (vol/vol) to disinfect the incision site.
4|
Make an incision (~10 mm) along the femur above the femoral triangle.
5|
Bluntly dissect the connective tissues with a hemostatic forceps, and expose the femoral artery, vein and nerve bundle.
6|
Expose 5-8 mm of femoral artery from the femoral neurovascular bundle by careful blunt dissection of the femoral nerve and vein with a hemostatic forceps.
7|
Ligate the femoral artery distally with a 4-0 silk suture, and then transiently block blood flow with an aneurysm clip at the proximal end of the femoral artery.
8| Place a 4-0 silk suture loosely around the femoral artery between the ligation and the clamped site.
9|
Create a partial arteriotomy between the two sutures with a microscissors, and then insert a sterile PE-50 tubing (400-500 mm) along the artery toward the proximal direction until it reaches the clamped site. Tighten the 4-0 silk suture between the ligation and clip to secure the tubing. Arterial blood collected in this length of the PE-50 tubing commonly generates ~10 individual clots that are suitable for MCAO. The length of the tubing can be varied depending on how many rats are scheduled for MCAO, up to 300 mm, which will generate ~6 emboli.
10|
Release the clip slowly to allow the blood to spontaneously flow into the tubing, and re-apply the clip immediately after the tubing is filled with blood.  crItIcal step To generate a uniform clot, it is essential that blood should flow smoothly and directly into the tubing. Any manipulations such as forcibly withdrawing the blood with a syringe during blood collection will lead to the formation of fragile segments of clots 24 h after collection, which are not suitable for MCAO.
11|
Remove the PE-50 tubing and immediately tie the suture.
12|
Remove the clip from the artery and close the incision with a 4-0 silk suture.
13|
Place the rat back into its home cage and allow recovery from anesthesia.
14| Place blood-containing PE-50 tubing in a Petri dish at 37 °C for 2 h, and subsequently retain it at 4 °C for an additional 22 h.  crItIcal step Lay blood-filled tubing flat and avoid unnecessary agitation during the 24-h incubation period.
preparation of endovascular cathethers • tIMInG 10-20 min 15| Turn on a gas burner, and adjust the fire to a low to medium flame. (Fig. 1) .
preparation of embolus • tIMInG 10-20 min 19| Fill a Petri dish (100 × 20 mm) with sterile saline, and prepare an ~500-mm PE-10 tubing with one end connected to a 1-cc saline-filled syringe.
20|
Cut the clot containing PE-50 tubing into ~50-mm segments in length, and connect the segment with the PE-10 tubing. Next, push the syringe to flush the clot out of the PE-50 tubing into the saline-filled Petri dish. If multiple MCAO procedures are planned in the same day, a longer segment of clot containing PE-50 tubing up to 300 mm can be used, which can generate ~6 emboli.
21|
Disconnect the PE-50 tubing from the PE-10 one. Draw and flush the clot into and out of the PE-10 tubing, respectively, 10-15 times to wash out the majority of the entrapped RBCs until the clot becomes white-pinkish in color (Fig. 1a) .  crItIcal step To avoid folding and twisting of the clot, always draw the clot from its end with the tubing, and place the clot into a straight line while flushing it back into the Petri dish.  crItIcal step Some clots remain red after 10-15 times of washing owing to their high RBC content. Although additional washes could eliminate the remaining RBCs, we do not recommend additional washes, as excessive washing may tangle the clot possibly owing to breakage or loss of fibrin strands. Therefore, we recommend that the clots that remain red in color after washing be discarded to maintain consistency of the experiments. ? trouBlesHootInG 22| Cut the washed clot into 40 mm in length and then collect it into the modified PE-50 catheter that is connected to a 100-µl Hamilton microsyringe. The clot is now ready to be used (Fig. 1c) . If multiple clots are made, the remaining clots can be stored in a saline-filled Petri dish at room temperature (20-26 °C) for up to 4 h and should be discarded thereafter.  crItIcal step If the clot contains many RBCs or is relatively fragile, the clot will be broken into segments when it is flushed out of the modified PE-50 catheter. Thus, when it is collected into the modified catheter, the clot should be flushed out of the catheter once to make sure that the clot remains intact. Only intact single clots can be used to block the MCA. During MCAO, the modified portion (tip) of the delivery catheter could be compressed by forceps that may cause damage to the contained clot. Therefore, in addition to avoiding unnecessary pressure while handling the catheter, the clot should be positioned ~22 mm distal to the tip of the catheter, which can eliminate potential damage to the clots (Fig. 2) .  pause poInt Clots can be stored in a saline-filled Petri dish at room temperature for up to 4 h. 
Mcao
• tIMInG 20-30 min 23| Anesthetize a rat using the anesthetic procedure described in Step 1, and prepare the incision site with standard aseptic procedure, as described in Steps 2 and 3.
24| Place the rat in supine position and hold both forelimbs laterally with surgical tapes to expose the ventral neck area.
25|
Make a 20-30-mm midline incision from the jaw to the shoulder, gently split the left and right sternohyoid muscles along the midline with blunt dissection and retract the right sternohyoid laterally to expose the trachea.
26|
Under an operating microscope and with careful blunt dissection, expose the right common carotid artery (CCA), which is situated deeply beneath the sternohyoid muscles and sits laterally to the trachea.
27|
Bluntly dissect the carotid sheath along the CCA rostrally until the ECA and ICA bifurcation is exposed without harming the vagal nerve, which also lies within the carotid sheath.  crItIcal step Care must be taken to avoid injury to the vagal nerve during dissection. Do not excessively compress or tug arteries with forceps, which could cause swelling or even rupture the arteries.
28|
Ligate the ECA along with occipital artery (the first branch of ECA) 2-3 mm distal to the bifurcation with two 4-0 silk sutures. Cut the ECA between the two ligations, and retract the proximal portion of the ECA stump laterally and caudally to align the ECA with the ICA (Fig. 2a) .  crItIcal step It is crucial that the ECA stump be positioned parallel to the CCA to advance the catheter into the intracranial segment of the ICA.
29|
Temporarily clamp the CCA and the ICA with an aneurysm clip, and apply a 4-0 silk suture loosely around the trunk of the ECA near the bifurcation. ? trouBlesHootInG 30| Create a partial arteriotomy on the ECA, and then insert the tip of the clot-filled modified PE-50 catheter into the arteriotomy. Advance the catheter rostrally toward the ICA until it reaches the clamp site. Tighten the 4-0 silk suture around the ECA trunk to secure the tubing. ? trouBlesHootInG 31| Release the clip slowly and further advance the catheter within the ICA rostrally to enter the intracranial segment of the ICA until resistance is felt. The total length of the catheter that has been advanced is ~19-22 mm from the ECA arteriotomy site.  crItIcal step The entire catheter along with the connected syringe should be aligned with the natural position of the ICA while advancing the catheter. This is essential for the catheter to successfully enter the intracranial segment of the ICA via bypassing the pterygopalatine artery, which branches from the extracranial segment of the ICA dorsally and medially (Fig. 2a) .
32|
Retract the catheter 1-2 mm, and slowly inject the clot with 5-10 µl of saline at a rate of 10 µl/min.  crItIcal step Slow injection is crucial, because this permits the clot to form a ball-like embolus large enough to obstruct the origin of the MCA. However, forced injection pushes the clot into a thread-like embolus that is unable to block the origin of the MCA (Fig. 1b) , and it will probably be washed away by blood flow when the catheter is withdrawn. 33| Retract the catheter 5 min after clot delivery until its tip reaches the ECA/ICA bifurcation. Re-apply an aneurysm clip to temporarily clamp the CCA and the ICA, and then withdraw the catheter from the arteriotomy. Tighten the 4-0 silk suture around the ECA trunk to ligate the arteriotomy. Remove the aneurysm clip.
34|
Close the incision site and terminate the anesthesia. Next, place the rat in the recovery area for further observation. Generally, the rat is awake within 5 min.
? trouBlesHootInG Troubleshooting advice can be found in table 2.
• tIMInG 
antIcIpateD results
At 24 h after clot injection, a single embolus should be lodged at the intracranial segment of the ICA at the origin of the MCA and/or at the M1 of the MCA without obstruction of the posterior communicating artery (PCA) (Fig. 2a,b) . Histological analysis should show an ischemic lesion in the territory of the right hemisphere supplied by the MCA (Fig. 2c,d) . We have an overall success rate of over 90% (469 of 500 rats) using this model based on the histological analysis of the ischemic lesions. The mortality rate within 7 d after stroke is <10% (7 of 85 rats). Sham-operated control rats do not show any ischemic lesions. MRI angiogram and perfusion-weighted imaging analysis should confirm occlusion of the right MCA immediately after delivery of the clot and substantial reduction of cerebral blood flow (CBF) within the territory supplied by the occluded MCA. Although the spontaneous recanalization of MCA occurs 24 h after MCAO in some cases, the hypoperfusion within the MCA territory persists (Fig. 3) .
Ultrastructure and immunohistochemistry analysis shows the formation of secondary thrombosis at the occluded origin of the MCA as evident by accumulation of platelets, fibrin and erythrocytes (Fig. 3b) . Moreover, secondary thrombosis is developed in downstream microvessels of the occluded MCA during 24 h, which is likely to contribute to the observed hypoperfusion by perfusion-weighted imaging (Fig. 3a,c,d ). The occurrence of secondary thrombosis following ischemic stroke is well described in stroke patients [35] [36] [37] [38] .
Neurological deficits are readily detectable immediately after recovery from anesthesia. Rats typically show contralateral forelimb flexion and circling behavior, which indicates contralateral hemiplegia. Further sophisticated sensorimotor Fig. 4; refs. 24,39-43). However, neurological deficits are not detected in sham-operated control rats. Our model has been widely used in evaluating the efficacy of various thrombolytic strategies 19, 21, 20, 44, 45 . Intravenous administration of rtPA within 2 h after stroke onset rapidly restores cerebral perfusion and reduces brain infarction. However, delayed treatment with rtPA at 4 h leads to an increased risk of hemorrhagic transformation, and it fails to restore blood flow and to reduce ischemic brain damage 20, 44, 45 . Our model bears a resemblance to the short therapeutic window and hemorrhagic complication observed in thrombolytic therapy in human stroke; thus, it could be used for studying the post-thrombolytic complications observed in some stroke patients. Indeed, this model has been widely used for the examination of multiple adjuvant pharmacological agents designed to enhance the efficacy and/or to reduce the adverse effects of thrombolytic therapy 17, 19, 23, 25, 26, [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] .
In conclusion, the embolic stroke model presented here enables a controlled delivery of an allogeneic clot to the origin of the MCA, which results in reproducible ischemic brain damage. Our model mimics the pathological features of the common type of ischemic stroke in patients, which inevitably represents a valuable animal model for translation stroke research. 42 , foot-fault test 40 and modified neurological severity score (mNSS) 39 
